Search Login Register

Mobility Limitation (Difficulty Walking) Summary

Description: Difficulty in walking from place to place.

Also Known As: Difficulty Walking; Ambulatory Difficulty; Difficulty Ambulation; Limitation, Mobility; Mobility Limitations Show All >>

Networked: 153 relevant articles (3 outcomes, 18 trials/studies) for this Disease

Key Drugs and Agents for Mobility Limitation

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Silicon Dioxide (Sand) : 1 outcome in 1 result : FDA 1 Generic
  2. Testosterone (Sustanon) : 7 studies in 11 results : FDA 13
  3. hydroquinone (Black and White) : 2 studies in 4 results : FDA 1
  4. hydroxide ion : 1 study in 4 results : IBA
  5. Parathyroid Hormone (Parathormone) : 1 study in 2 results : IBA
  6. Lipoproteins (Lipoprotein) : 1 study in 1 result : IBA
  7. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme) : 1 study in 1 result : IBA
  8. 25-hydroxyvitamin D : 1 study in 1 result : IBA
  9. oxidized low density lipoprotein : 1 study in 1 result : IBA
  10. Interleukin-6 (Interleukin 6) : 5 results : IBA
Show All >>

Diseases Related to Mobility Limitation

  1. Pain (Aches)
  2. Dizziness (Lightheadedness)
  3. Hypesthesia (Numbness)
  4. Mobility Limitation (Difficulty Walking)
  5. Prediabetic State (Prediabetes)
Show All >>

Key Therapies for Mobility Limitation

Efficacy Chart >>
  1. Activities of Daily Living (ADL) : 1 outcome 3 studies in 53 results
  2. Resistance Training : 1 outcome in 3 results
  3. Self-Help Devices (Assistive Technology) : 1 study in 8 results
  4. Institutionalization (Institutionalized Persons) : 1 study in 4 results
  5. Bariatric Surgery : 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.